Log In
Print
BCIQ
Print
Print this Print this
 

Poly-ICLC (Hiltonol)

  Manage Alerts
Collapse Summary General Information
Company Oncovir Inc.
DescriptionDouble-stranded ribonucleic acid (dsRNA)
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationBrain cancer
Indication DetailsTreat brain cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today